Evaluation of Tc-99m Tetrofosmin Scan for Coronary Artery Disease Diagnosis by Ghanem, Georges et al.
ASIAN CARDIOVASCULAR & THORACIC ANNALS 244 2002, VOL. 10, NO. 3
Tc-99m Tetrofosmin Scan Chammas
For reprint information contact:
Elie Chammas, MD   Tel: 961 1 20 0800   Fax: 961 1 32 1521   email: echammas@inco.com.lb
Department of Cardiology, Rizk Hospital, P.O. Box 11-3288, Achrafieh, Beirut, Lebanon.
ORIGINAL CONTRIBUTION
Evaluation of Tc-99m
Tetrofosmin Scan for
Coronary Artery Disease
Diagnosis
Elie Chammas, MD, Ahmad Yatim, MD1,
Chadi Hage, MD, Kozhaya Sokhn, MD,
Walid Tarcha, MD, Georges Ghanem, MD
Department of Cardiology
1Department of Nuclear Medicine
Rizk Hospital
Beirut, Lebanon
ABSTRACT
Detection of myocardial perfusion abnormalities using Tc-99m tetrofosmin was
evaluated for sensitivity and specificity compared to coronary angiography. Between
January 1996 and January 1998, exercise stress tests and myocardial scintigraphy
were performed in 58 patients, followed by coronary angiography within 2 months.
There were 48 males and 10 females, aged 33 to 72 years (mean, 57 years). The
sensitivity and specificity of exercise stress tests were 64% and 68%, respectively,
while the sensitivity and specificity of Tc-99m tetrofosmin scans were 88% and
75%, respectively, compared to angiography. For Tc-99m tetrofosmin scans, the
sensitivity was 78% for the left anterior descending artery, 66% for the left
circumflex artery, and 76% for the right coronary artery; specificity was 74% for
the left anterior descending artery, 90% for the left circumflex artery, and 75% for
the right coronary artery. It was concluded that Tc-99m tetrofosmin allowed high-
quality myocardial perfusion imaging with results comparable to those obtained
using thallium-201 chloride.
(Asian Cardiovasc Thorac Ann 2002;10:244–7)
INTRODUCTION
The use of nuclear techniques for noninvasive studies of
cardiovascular disease is well established. Nuclear
cardiology provides unique pathophysiological insights
unavailable by other procedures.1,2 Thallium-201 is still
the most widely used agent in myocardial perfusion
imaging for diagnosis of exercise-induced myocardial
ischemia, and evaluation of the site and extent of post-
infarction scarring and myocardial viability.3,4 However,
technetium-99m has certain advantages over thallium-
201, and the use of Tc-99m-labeled pharmaceuticals in
cardiology is increasing.1,2 The newest Tc-99m-labeled
agent used in nuclear medicine is tetrofosmin.5
LEBANON
PATIENTS AND METHODS
A prospective study was conducted in this hospital between
January 1996 and January 1998, to assess the diagnostic
efficacy of Tc-99m tetrofosmin in cases of known or
suspected coronary artery disease. There were 58
consecutive patients (48 males and 10 females), aged 33
to 72 years (mean, 57 years). Patients were considered
eligible for this study if they had clinical symptoms
suggestive of coronary artery disease, a past history of
myocardial infarction, a baseline electrocardiogram (ECG)
with premature ventricular contractions, or such ECG
findings after a revascularization procedure. Exclusion
criteria were recent myocardial infarction (within 2
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months), unstable angina, significant congestive heart
failure, valvular disease, left bundle branch block,
congenital heart disease, and significant concomitant
noncardiac disease. Each patient had Tc-99m tetrofosmin
stress and resting imaging studies of 4 hours’ duration,
and coronary arteriography 1 to 47 days later (mean, 14
days). All patients underwent a symptom-limited upright
bicycle exercise test using stepwise increments of 30
watts every 3 minutes. The ECG and arterial blood pressure
were monitored continuously and recorded before and at
2-minute intervals during exercise and recovery. Exercise
stress testing was conducted on a Marquette case 15
stress test system (GE Medical Systems, Inc., Milwaukee,
WI, USA). A test was considered submaximal if the
attained maximum heart rate was below 85% of the
predicted maximum heart rate (220 minus the patient’s
age in years). An ischemic response was defined as typical
chest pain and/or ST depression > 1 mm with a horizontal
or downward sloping segment, or ST elevation without
evidence of myocardial infarction.
A Sopha single-head DSX tomograph (GE Medical
Systems, Inc., Milwaukee, WI, USA) was used for all
patients. A solution of Tc-99m tetrofosmin was prepared
from a freeze-dried kit (Myoview; Amersham Health,
Little Chalfont, Buckinghamshire, England, UK)
conserved in a 10-mL glass vial stored at 2°C to 8°C. The
vial was reconstituted with 5 mL of sodium pertechnetate
solution by diluting the eluate from a technetium-99m
generator with 0.9% saline. The vial was shaken gently
to insure complete dissolution of the lyophilized powder,
and left at room temperature (15°C to 25°C) for 15
minutes, according to the manufacturer’s instructions.
The injection was used within 6 hours of reconstitution.
A dose of 7 mCi of Tc-99m tetrofosmin was injected at
peak exercise, and 20 mCi 4 hours thereafter; the images
began to appear 30 minutes after each injection. The
perfusion pattern was assessed by single photon emission
computed tomography in 5 segments: anterior, inferior,
lateral, septal, and apical; which were described as either
normal, reversible, or fixed abnormality (scar). Perfusion
abnormalities (ischemia) in the anteroseptal area reflected
disease of the left anterior descending artery (LAD),
those in the inferior wall were due to right coronary artery
(RCA) disease, and those in the posterolateral wall
represented disease in the left circumflex artery (LCx).
Apical abnormalities were not specific for any of these
3 vascular territories. Selective coronary angiography
was performed in multiple views by the Judkins technique,
using a Philips angiographic system (Philips Medical
Systems, Vienna, Austria). Coronary arteriography results
were considered positive if significant stenosis (> 60%),
diffuse, or multiple lesions were visualized in at least one
major vessel.
RESULTS
Of the 58 patients with suspected coronary artery disease,
34 were taking cardiac medications (Figure 1), 17 (29%)
were hypertensive, 9 of whom (53%) were receiving
appropriate treatment and 8 (47%) were untreated.
Coronary arteriography was positive in 45 patients:
12 (27%) had single-vessel disease, 20 (44%) had double-
vessel disease, and 13 (29%) had triple-vessel disease.
There were 35 LAD lesions, 31 RCA lesions, and 25 LCx
lesions.
In stress tests, the attained maximum heart rates were
between 67% and 104% of the predicted maximum heart
rates. The mean load was 143 watts, and the normal
interval was 70 to 210 watts. No patient developed stress-
test complications. The test was negative in 30 patients
(52%) and positive in 28 (48%), of whom 28% attained
submaximal effort. Based on coronary angiography, the
sensitivity was calculated as 64% and the specificity was
68%.
Perfusion scans were negative in 12 patients (21%). A
perfusion defect was observed in 46 patients (79%), of
whom 8 had irreversible defects; 7 of them had positive
angiograms that correlated with the ischemic segments,
but one appeared to have normal coronary arteries on
angiography. Of the 24 patients showing reversible
perfusion defects, 20 had corresponding significantly
diseased coronary arteries, and the others (2 septal,
1 anterior, 1 inferior) had completely normal angiograms.
The remaining patients showed fixed lesions with
corresponding abnormal coronaries. Among the 22
hypertensives, 2 of the 17 patients with normal angiograms
had a positive scan, indicating a 12% false-positive rate.
These anomalous perfusion defects appeared in the septum,
correlating with well-known septal false-positive Tc-99m
tetrofosmin results in the hypertensive population.6 The
overall sensitivity and specificity of Tc-99m tetrofosmin
was calculated as 88% and 75%, respectively, compared
to coronary angiography. The sensitivity was 78% for the
LAD, 66% for the LCx, and 76% for the RCA. Specificity
was 74% for the LAD, 90% for the LCx, and 75% for the
RCA.
DISCUSSION
Myocardial scintigraphy and coronary angiography
are two complementary investigations, one giving a
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Figure 1. Cardiac medications in 34 patients. ACE = angiotensin-
converting enzyme inhibitor, BB = beta blocker, CCB = calcium channel
blocker.
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physiologic assessment of myocardial perfusion, the other
providing an anatomic description of coronary lesions.
When this study began, the use of Tc-99m tetrofosmin
was just starting in the United States, but its role in
nuclear cardiology, especially in the diagnosis and
management of coronary artery disease, has become well
defined.7 Tetrofosmin offers many advantages over other
products because of its biophysical and biokinetic
properties.8,9 In this study, stress test specificity (64%)
was the same as the internationally established specificity
(mean, 66%; range, 17% to 100%); however, stress test
sensitivity (68%) was lower (mean, 82%; range, 40% to
100%).10 The fact that 59% of patients were receiving
medication is a possible explanation for the small
differences in the results. It was difficult to obtain a
statistical comparison between patients under treatment
and those without medication, because of the limited
numbers. Hypertensive patients accounted for 25% in
this study; it has been demonstrated that hypertension
increases the incidence of false-positive results, thus
decreasing the specificity of the Tc-99m tetrofosmin scan.
The effect of longstanding hypertension on myocardial
perfusion imaging is still controversial.6 It is well
established that hypertension increases the positivity of
stress tests. A positive coronary angiography threshold of
stenosis of 60% instead of 70% to 75% increases the
sensitivity of the test, but decreases its specificity. The
predictive value of Tc-99m tetrofosmin scans was highest
in the mixed-lesion group, and the presence of associated
reversible and irreversible perfusion defects at the same
site was indicative of a corresponding coronary lesion.
This series consisted of only 58 patients, and such a small
number might influence the reproducibility of the results.
A substantially larger number is obtainable only in a
multicenter study. There were 34 patients under various
medical treatments that appeared to affect the results of
both stress testing and Tc-99m tetrofosmin scanning, which
was due to the fact that the majority were referred by
cardiologists using different modes of therapy. Cardiac
medications could blunt positive stress test results and
prevent the patient from reaching the maximum predicted
effort. Because of the heterogeneity of the population,
dipyridamole stress testing was not undertaken.
Coronary angiography has been considered the gold
standard for assessing the severity and extent of coronary
artery disease. However, several limitations have been
recognized: the planar perspective of angiography may
significantly misrepresent the severity of complex luminal
narrowing because it provides only a silhouette of the
lumen.10 Two orthogonal angiograms should adequately
portray most lesions, but orthogonal views may be difficult
to obtain in the clinical setting, especially when the disease
involves bifurcation sites and tortuous segments. In fact,
some coronary narrowings are so complex, particularly
following angioplasty, that no combination of angiographic
views may accurately depict their extent. Necropsy studies
have demonstrated that coronary disease is frequently
diffuse with no truly normal segment from which to
calculate the percentage reduction in diameter. Thus, in
the presence of diffuse disease, angiography may
systematically underestimate disease severity. In addition
to important discrepancies between antemortem
angiography and necropsy findings, large intra- and
interobserver variability has been noted, as well as a poor
correlation between the angiographic appearance of
coronary obstruction and the physiological consequences
of the lesions.11 Furthermore, coronary angiography is
unable to assess the significance of collaterals perfusing
chronically ischemic myocardium. These collaterals
mainly consist of microvessels that are not accurately
visualized by standard imaging techniques. Therefore, a
severely stenotic coronary artery might correspond to a
well-perfused segment that would not meet the
physiological criteria for determining stenosis.
It was concluded from this study that Tc-99m tetrofosmin
provided high-quality myocardial perfusion imaging with
results comparable to those obtained with the widely used
thallium-201 chloride. Because of the advantages of
Tc-99m over Tl-201, we recommend that thallium should
be reserved for studies concerning myocardial viability,
while awaiting the results of studies on the use of Tc-99m
agents for evaluation of myocardial viability.
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